论文部分内容阅读
目的:探讨康复新液联合胶体果胶铋兰索拉唑四联在难治性消化性溃疡治疗中临床效果。方法:采用随机数字表法为分组依据,将2016年1月至2017年1月就诊于我院的120例难治性消化性溃疡患者分为胶体果胶铋兰索拉唑四联治疗的对照组与康复新液联合胶体果胶铋兰索拉唑四联治疗的观察组,以治疗的总有效率和疾病的复发率作为观察指标,对比分析两组的近期和远期治疗效果。结果:从近期效果看,观察组患者的治疗总有效率明显高于对照组,从远期效果看,观察组患者疾病的复发率显著低于对照组;两组间进行统计学比较,P<0.05有意义,观察组治疗效果更佳。结论:康复新液联合胶体果胶铋兰索拉唑四联治疗难治性消化性溃疡效果显著,能够明显增强治疗效果,降低疾病的复发率,治疗效果更为彻底,临床价值高,可作为治疗消化性溃疡的首选方案,广泛推行。
Objective: To investigate the clinical effect of Kangfuxin Solution combined with colloidal pectin bismuth lansoprazole quadruplex in the treatment of refractory peptic ulcer. Methods: A random number table method was used as a group basis. One hundred and twenty patients with refractory peptic ulcer referred to our hospital from January 2016 to January 2017 were divided into four groups: control group treated with colloidal pectin bismuth lansoprazole Group and Kangfuxin solution combined colloidal pectin bismuth lansoprazole quadruple-treatment group, the total effective rate of treatment and disease recurrence rate as an index to compare the two groups of short-term and long-term treatment. Results: From the short-term results, the total effective rate of observation group was significantly higher than that of control group. From the long-term effect, the recurrence rate of disease in observation group was significantly lower than that of control group. Statistical comparison was made between the two groups (P < 0.05 significant, observation group treatment better. CONCLUSION: Kangfuxin solution combined with colloidal pectin bismuth lansoprazole quadruple therapy has a significant effect on refractory peptic ulcer, which can significantly enhance the therapeutic effect and reduce the recurrence rate of the disease. The treatment effect is more thorough and the clinical value is high. The treatment of peptic ulcer preferred program, widely implemented.